HomeInsights52 Week Low Stocks

Glaxosmithkline Pharmaceuticals Ltd 52 Week Low

Glaxosmithkline Pharmaceuticals Ltd 52 Week Low

stocks purchased

₹ 0.3 Cr

Volume Transacted

(Dec 27, 2024)

stocks purchased

1.3 K

Stocks Traded

(Dec 27, 2024)

Last Updated on: Dec 28, 2024

Image

Glaxosmithkline Pharmaceuticals Ltd

NSE: GLAXO

YEARLOW

₹ 1799.05

Last updated on: Dec 27, 2024

Key Highlights

  • The 52 Week Low of Glaxosmithkline Pharmaceuticals Ltd is ₹ 1799 as of 27 Dec 24 .

Company Fundamentals for Glaxosmithkline Pharmaceuticals Ltd

No data available

Market Price of Glaxosmithkline Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Glaxosmithkline Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
27 Dec 20242271.05
26 Dec 20242241.8
24 Dec 20242265.1
23 Dec 20242282.85
20 Dec 20242284.5
19 Dec 20242325.25
18 Dec 20242334.95
17 Dec 20242264.65
16 Dec 20242278.95
13 Dec 20242254.45

Asset Value vs Market Value of Glaxosmithkline Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Glaxosmithkline Pharmaceuticals Ltd News Hub

News

GSK Pharma gains as Q2 PAT rises 15% YoY to Rs 249 cr

Profit before exceptional item and tax was at Rs 338.70 crore in the September 2024 quarte...

Read more

30 Oct 2024 10:39

News

Board of GlaxoSmithKline Pharmaceuticals recommends Special Interim Dividend

GlaxoSmithKline Pharmaceuticals announced that the Board of Directors of the Company at it...

Read more

29 Oct 2024 16:10

News

GlaxoSmithKline Pharmaceuticals to declare Quarterly Result

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

25 Oct 2024 10:38

News

GSK Pharma Q1 PAT climbs 39% YoY to Rs 182 crore

Revenue from operations grew by 9.89% year on year (YoY) to Rs 811 crore during the quarte...

Read more

03 Aug 2024 12:25

News

GlaxoSmithKline Pharmaceuticals to convene board meeting

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

18 Jul 2024 10:38

News

Glaxosmithkline Pharmaceuticals announces change in senior management

Glaxosmithkline Pharmaceuticals announced that Dr. Shalini Menon has been appointed as Exe...

Read more

05 Jul 2024 13:26

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Glaxosmithkline Pharmaceuticals Ltd

Why is it important to track the 52-week low of Glaxosmithkline Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Glaxosmithkline Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Glaxosmithkline Pharmaceuticals Ltd stocks hitting a 52-week low?

Factors leading to Glaxosmithkline Pharmaceuticals Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Glaxosmithkline Pharmaceuticals Ltd stocks when they hit a 52-week low?

Buying Glaxosmithkline Pharmaceuticals Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Glaxosmithkline Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Glaxosmithkline Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Glaxosmithkline Pharmaceuticals Ltd stock at their 52-week low?

An investor can analyze the reasons for the Glaxosmithkline Pharmaceuticals Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Glaxosmithkline Pharmaceuticals Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Glaxosmithkline Pharmaceuticals Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Glaxosmithkline Pharmaceuticals Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions